Labelling can be remedied, whereas a product that is ineffectual, or one with a poor safety profile cannot.
this has passed the most challenging hurdle. Delays are a punish, but that’s pharma.
Ann: FDA Letter Requires Patient Instruction Update, page-43
-
- There are more pages in this discussion • 253 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
-0.015(4.35%) |
Mkt cap ! $610.8M | |||
| Open | High | Low | Value | Volume |
| 34.5¢ | 34.5¢ | 33.0¢ | $3.124M | 9.257M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 42 | 2728651 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 675218 | 13 |
View Market Depth
| Last trade - 12.56pm 01/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |